US Stock MarketDetailed Quotes

CVKD Cadrenal Therapeutics

Watchlist
  • 15.420
  • -1.430-8.49%
Close Mar 10 16:00 ET
  • 15.420
  • 0.0000.00%
Post 20:01 ET
27.49MMarket Cap-2.50P/E (TTM)

Cadrenal Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Cadrenal Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Cadrenal Therapeutics Earnings Reports

  • Cadrenal Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 7, 2024 16:04 ET

  • Cadrenal Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 7, 2024 16:09 ET

  • Cadrenal Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 9, 2024 06:27 ET

  • Cadrenal Therapeutics | 10-K: FY2023 Annual Report

    Mar 11, 2024 12:58 ET

    • Read more

    Trending Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Lantheus
    LNTH
    +3.45%
    Collegium Pharmaceutical
    COLL
    +2.59%
    Constellation Brands
    STZ
    +1.73%
    Halozyme Therapeutics
    HALO
    +0.75%
    AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
    AIPUY
    0.00%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Mar 5, 2025

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data